Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:
  • Completed  
  • « Prev · Page 260

NCT ID: NCT00000461 Completed - Clinical trials for Cardiovascular Diseases

Harvard Atherosclerosis Reversibility Project (HARP)

Start date: December 1986
Phase: Phase 2
Study type: Interventional

To determine by sequential coronary arteriography whether a lipid-lowering diet with and without lipid-lowering drugs could reverse coronary artery disease in normocholesterolemic patients. Also, to test whether fish oil supplements could improve human coronary atherosclerosis. Finally, to determine the effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. At least three clinical trials were conducted.

NCT ID: NCT00000459 Completed - Clinical trials for Cardiovascular Diseases

Dietary Intervention Study in Children (DISC)

Start date: December 1986
Phase: Phase 3
Study type: Interventional

To assess the feasibility, acceptability, efficacy, and safety of dietary intervention in free-living children ages 8-10 with elevated low density lipoprotein cholesterol levels.

NCT ID: NCT00000108 Completed - Clinical trials for Cardiovascular Diseases

Effects of Training Intensity on the CHD Risk Factors in Postmenopausal Women

Start date: n/a
Phase: N/A
Study type: Interventional

The purpose of this research is to find out whether training at different exercise intensities reduces the risk of developing cardiovascular disease (CVD) to a different extent. Heart attacks and stroke are the leading cause of death in older women. Reduced variability of the heart rate and increased dips and swings in blood pressure are risks factors that predict the chance of developing CVD as are increased levels of clotting protein fibrinogen and plasminogen activator inhibitor 1, and high levels of LDL-cholesterol (>160mg/dl). We will be measuring all of these risk factors and any changes in your body fat level before you start training and after 15 and 30 weeks of training in the form of walking. At the present time the effects of exercise intensity on these factors are not well understood. This study will add to the basic understanding of these issues and allow us to recommend to postmenopausal women optimal exercise intensities to lose body fat and reduce the risk of developing CVD.